drugset / Trial / NCT01746641

Remifentanil Versus Propofol for TCI Sedation of Patients Undergoing Gastrointestinal Endoscopic Procedures

NCT01746641 ↗

RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study was to compare remifentanil and propofol for sedation of patients during endoscopic gastrointestinal procedures.

Timeline

Start
2010-01
Primary completion
2010-06
Completion
2010-06

Outcome

Outcome not reported

Stopped: “Occurrence of severe respiratory depression in the remifentanil group.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 1 ug/ml —
Comparator Remifentanil Small molecule 1 ng/ml —

Indications

No indication recorded.